Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ohori

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
The Tohoku Journal of Experimental Medicine|August 1, 1988
Severe acute exacerbation in chronic hepatitis B virus infection in Sendai, JapanA Kanno, H Suzuki, Y Miyazaki, et al.
Journal of Medical Virology|August 1, 1995
Prevalence of precore-defective mutant of hepatitis B virus in HBV carriersH Niitsuma, M Ishii, Y Saito, et al.
The Tohoku Journal of Experimental Medicine|December 1, 1993
Relationship between molecular state of serum HBV-DNA and clinical features of hepatitis B virus carriersS Sato, M Yamada, Y Miyazaki, et al.
Hepatology (Baltimore, Md.)|January 1, 1987
Virological significance of HBeAg subtypes (HBeAg/1 and HBeAg/2) in patients with type B hepatitisA Kanno, H Ohori, K Matsuda, et al.
Journal of Medical Virology|January 1, 1983
An antigen/antibody system specific for an epidemic non-A, non-B hepatitis in patients of a cardiovascular surgical unitH Ohori, A Kanno, Y Nagatsuka, et al.
Cancer Causes & Control : CCC|July 1, 1993
Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors: a cross-sectional studyA Fukao, S Komatsu, Y Tsubono, et al.
ESMO Open|May 7, 2025
Genome-wide DNA methylation status as a biomarker for clinical outcomes of first-line treatment in patients with RAS wild-type metastatic colorectal cancer: JACCRO CC-13ARK Ouchi, Y Sunakawa, A Tsuji, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 3, 2018
S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer (TRICOLORE): a randomized, open-label, phase III, noninferiority trialY Yamada, T Denda, M Gamoh, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The Tohoku Journal of Experimental Medicine|August 1, 1988
Severe acute exacerbation in chronic hepatitis B virus infection in Sendai, JapanA Kanno, H Suzuki, Y Miyazaki, et al.
Journal of Medical Virology|August 1, 1995
Prevalence of precore-defective mutant of hepatitis B virus in HBV carriersH Niitsuma, M Ishii, Y Saito, et al.
The Tohoku Journal of Experimental Medicine|December 1, 1993
Relationship between molecular state of serum HBV-DNA and clinical features of hepatitis B virus carriersS Sato, M Yamada, Y Miyazaki, et al.
Hepatology (Baltimore, Md.)|January 1, 1987
Virological significance of HBeAg subtypes (HBeAg/1 and HBeAg/2) in patients with type B hepatitisA Kanno, H Ohori, K Matsuda, et al.
Journal of Medical Virology|January 1, 1983
An antigen/antibody system specific for an epidemic non-A, non-B hepatitis in patients of a cardiovascular surgical unitH Ohori, A Kanno, Y Nagatsuka, et al.
Cancer Causes & Control : CCC|July 1, 1993
Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors: a cross-sectional studyA Fukao, S Komatsu, Y Tsubono, et al.
ESMO Open|May 7, 2025
Genome-wide DNA methylation status as a biomarker for clinical outcomes of first-line treatment in patients with RAS wild-type metastatic colorectal cancer: JACCRO CC-13ARK Ouchi, Y Sunakawa, A Tsuji, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 3, 2018
S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer (TRICOLORE): a randomized, open-label, phase III, noninferiority trialY Yamada, T Denda, M Gamoh, et al.
Pageof 4